GHA
WST icon

GW Henssler & Associates’s West Pharmaceutical WST Stock Holding History

GW Henssler & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,589
Closed -$394K – 236
2020
Q1 		$394K Sell
2,589
-125
-5% -$19.2K 0.04% 117
2019
Q4 		$408K Buy
2,714
+514
+23% +$74.8K 0.03% 159
2019
Q3 		$312K Sell
2,200
-700
-24% -$96.4K 0.03% 170
2019
Q2 		$363K Buy
2,900
+184
+7% +$21.7K 0.03% 164
2019
Q1 		$299K Buy
+2,716
New +$283K 0.03% 182

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

GW Henssler & Associates's WST Position: Q2 2020 in Review

GW Henssler & Associates sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 2,589 shares — an estimated $394K sold.

GW Henssler & Associates first reported a position in WST in Q1 2019 and held it in 5 quarters. The position peaked at $408K in Q4 2019. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • GW Henssler & Associates reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • GW Henssler & Associates sold 2,589 West Pharmaceutical shares in Q2 2020, an estimated $394K.
  • GW Henssler & Associates first reported a position in West Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • GW Henssler & Associates's West Pharmaceutical position peaked at $408K in Q4 2019.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on GW Henssler & Associates's 13F filing for Q2 2020, filed 21 Jul 2020.